| NCT ID | NCT07216599 |
| Status | Recruiting |
| Phase | — |
| Sponsor | State University of New York at Buffalo |
| Condition | Foot Ulcer |
| Study Type | INTERVENTIONAL |
| Enrollment | 25 participants |
| Start Date | 2025-10-28 |
| Primary Completion | 2026-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 25 participants in total. It began in 2025-10-28 with a primary completion date of 2026-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This pilot device trial aims to test the feasibility of using photoacoustic images to monitor tissue perfusion and to guide post-surgical wound treatment. Through this pilot study, the investigators will test the feasibility, identify any practical issues, and acquire essential information (e.g., drop-off rate, variation in wound healing rate) to guide future large-scale studies.
Eligibility Criteria
Inclusion Criteria: * Patients with a chronic wound on the foot that is presumed to be due to arterial insufficiency. Exclusion Criteria: * Patients with a massive deep tissue infection. * Patients with preexisting skin conditions, such as melanoma, psoriasis, in areas close to the wound(s). * Noncompliant patients who do not adhere to care plans. * Pregnant women. * Adults unable to consent.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07216599 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Foot Ulcer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07216599 currently recruiting?
Yes, NCT07216599 is actively recruiting participants. Contact the research team at junxia@buffalo.edu for enrollment information.
Where is the NCT07216599 trial being conducted?
This trial is being conducted at Buffalo, United States.
Who is sponsoring the NCT07216599 clinical trial?
NCT07216599 is sponsored by State University of New York at Buffalo. The trial plans to enroll 25 participants.